Namaste Technologies Bringing Telemedicine for Medicinal Marijuana to Canada
Namaste Technologies is rolling out a telemedicine portal to connect doctors to medical marijuana patients virtually. The company's co-founder and CEO Sean Dollinger explains how they are bringing this technology to the Canadian market.
"NamasteMD is the first application allowed by the app store for telemedicine in Canada ever for cannabis," said Dollinger. He explains his hope for Namaste Technologies to become a global leader in cannabis by leveraging its technology for partners in the market.
The company is projecting $30 million in revenue for this year.
Namaste Technologies launched in 2014 as a hardware company producing vaporizers. "It allowed us to develop a platform that collected a database and customers around the world," said Dollinger.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
